Cargando…
Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial
BACKGROUND: Guidance is needed on best medical management for advanced HIV disease with multidrug resistance (MDR) and limited retreatment options. We assessed two novel antiretroviral (ARV) treatment approaches in this setting. METHODS AND FINDINGS: We conducted a 2×2 factorial randomized open labe...
Autores principales: | Holodniy, Mark, Brown, Sheldon T., Cameron, D. William, Kyriakides, Tassos C., Angus, Brian, Babiker, Abdel, Singer, Joel, Owens, Douglas K., Anis, Aslam, Goodall, Ruth, Hudson, Fleur, Piaseczny, Mirek, Russo, John, Schechter, Martin, Deyton, Lawrence, Darbyshire, Janet |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069000/ https://www.ncbi.nlm.nih.gov/pubmed/21483491 http://dx.doi.org/10.1371/journal.pone.0014764 |
Ejemplares similares
-
The VACS Index Accurately Predicts Mortality and Treatment Response among Multi-Drug Resistant HIV Infected Patients Participating in the Options in Management with Antiretrovirals (OPTIMA) Study
por: Brown, Sheldon T., et al.
Publicado: (2014) -
2432: A close examination of anti-retroviral drug selection and management in the optima study
por: Huang, Yuan, et al.
Publicado: (2018) -
Decisiones optimas financieras
por: Robicheck, Alexander
Publicado: (1972) -
Decisiones óptimas financieras /
por: Robichek, Alexander A.
Publicado: (1968) -
Kwaliteiten optimaal benutten
por: STALPERS, DEWI
Publicado: (2021)